POTASSIUM CITRATE
POTASSIUM CITRATE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: POTASSIUM CITRATE; Generic name: POTASSIUM CITRATE; Manufacturer: REMEDYREPACK INC..
| Brand name | POTASSIUM CITRATE |
|---|---|
| Generic name | POTASSIUM CITRATE |
| Manufacturer | REMEDYREPACK INC. |
| Used for | 1 INDICATIONS AND USAGE Potassium citrate extended-release tablets are a citrate salt of potassium indicated for the management of: Renal tubular acidosis (RTA) with calcium stones (1.1) Hypocitraturic calcium oxalate nephrolithiasis of any etiology (1.2) Uric acid lithiasis with or without calcium stones (1.3) 1.1 Renal Tubular Acidosis (RTA) with Calcium Stones Potassium citrate is indicated for the management of renal tubular acidosis [see Clinical Studies (14.1)]. 1.2 Hypocitraturic Calcium Oxalate Nephrolithiasis of any Etiology Potassium citrate is indicated for the management of Hypocitraturic calcium oxalate nephrolithiasis [see Clinical Studies (14.2)] . 1.3 Uric Acid Lithiasis with |
| Dosage | 2 DOSAGE AND ADMINISTRATION Objective: To restore normal urinary citrate (greater than 320 mg/day and as close to the normal mean of 640 mg/day as possible), and to increase urinary pH to a level of 6.0 to 7.0. Severe hypocitraturia (urinary citrate < 150 mg/day): therapy should be initiated at 60 mEq per day; a dose of 30 mEq two times per day or 20 mEq three times per day with meals or within 30 minutes after meals or bedtime snack (2.2) Mild to moderate hypocitraturia (urinary citrate >150 mg |
| Active ingredient(s) | POTASSIUM CITRATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=08c769d4-1dc0-4130-8f9c-cddace13a79b |